Clinical Trial Update: Study of Duloxetine vs Placebo in Treatment of Binge Eating Disorder With Depression [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing duloxetine to placebo for binge eating disorder with depression has completed, and the results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Binge Eating Disorder
• Major Depressive Disorder

Drugs mentioned

• Duloxetine (DULOXETINE)

Snippet

Sponsor: University of Cincinnati | Conditions: Binge Eating, Depression | Phase 4 | Status: COMPLETED | Results posted: 2012-11-14